On February 24, 2022, the Justice Department filed a complaint against the Unified Judicial System of Pennsylvania (UJS) for violating Title II of the ADA by prohibiting the use of lawfully prescribed medication to treat Opioid Use Disorder by individuals under court supervision. The department previously notified the UJS that its courts had engaged in discrimination in a letter of findings issued on February 2, 2022. That letter demanded that the UJS address the violations identified by taking corrective actions, including revising relevant policies, appropriately training relevant personnel, and paying compensatory damages to aggrieved individuals. On July 1, 2022, the Justice Department filed the opposition to UJS’s motion to dismiss.
Press Release Letter of Findings